Advanced search
1 file | 395.81 KB Add to list

The utility of biomarkers in prognosis assessment of patients with acute liver failure

Author
Organization
Abstract
Background: Acute liver failure (ALF) is a rare but potential lethal condition characterized by the sudden development of jaundice, coagulopathy and hepatic encephalopathy in patients without underlying liver disease. In selected patients, emergency liver transplantation is required. Selection of these patients is based on clinical criteria such as the Kings College Criteria (KCC) or the Clichy criteria. Aims: The aim of this work is to provide an overview of potential biomarkers that could improve the prognostic value of KCC. Results: Several promising biomarkers involved in related pathophysiological processes have been identified. Some could be as stand-alone biomarkers; however, the best prognostic values have been observed in the combination of biomarkers with current models. Among these, the ALFSG Index that combines clinical parameters and circulating blood levels of CK18 claims a higher prognostic value than KCC. Conclusions: In this review, all potential biomarkers for ALF have been summarized to give an overview of the work performed over the last years, and a glimpse of what to expect in this field in the coming years.
Keywords
FREE GC-GLOBULIN, ALPHA-FETOPROTEIN, PREDICTIVE-VALUE, SPONTANEOUS-RECOVERY, FULMINANT-HEPATITIS, ARTERIAL AMMONIA, BLOOD, LACTATE, SERUM-LEVELS, CELL-DEATH, TRANSPLANTATION, acute liver failure, biomarker, prognosis

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 395.81 KB

Citation

Please use this url to cite or link to this publication:

MLA
De Clercq, Pauline, et al. “The Utility of Biomarkers in Prognosis Assessment of Patients with Acute Liver Failure.” HEPATOLOGY RESEARCH, 2021, doi:10.1111/hepr.13668.
APA
De Clercq, P., Geerts, A., Van Vlierberghe, H., & Verhelst, X. (2021). The utility of biomarkers in prognosis assessment of patients with acute liver failure. HEPATOLOGY RESEARCH. https://doi.org/10.1111/hepr.13668
Chicago author-date
De Clercq, Pauline, Anja Geerts, Hans Van Vlierberghe, and Xavier Verhelst. 2021. “The Utility of Biomarkers in Prognosis Assessment of Patients with Acute Liver Failure.” HEPATOLOGY RESEARCH. https://doi.org/10.1111/hepr.13668.
Chicago author-date (all authors)
De Clercq, Pauline, Anja Geerts, Hans Van Vlierberghe, and Xavier Verhelst. 2021. “The Utility of Biomarkers in Prognosis Assessment of Patients with Acute Liver Failure.” HEPATOLOGY RESEARCH. doi:10.1111/hepr.13668.
Vancouver
1.
De Clercq P, Geerts A, Van Vlierberghe H, Verhelst X. The utility of biomarkers in prognosis assessment of patients with acute liver failure. HEPATOLOGY RESEARCH. 2021;
IEEE
[1]
P. De Clercq, A. Geerts, H. Van Vlierberghe, and X. Verhelst, “The utility of biomarkers in prognosis assessment of patients with acute liver failure,” HEPATOLOGY RESEARCH, 2021.
@article{8711437,
  abstract     = {{Background: Acute liver failure (ALF) is a rare but potential lethal condition characterized by the sudden development of jaundice, coagulopathy and hepatic encephalopathy in patients without underlying liver disease. In selected patients, emergency liver transplantation is required. Selection of these patients is based on clinical criteria such as the Kings College Criteria (KCC) or the Clichy criteria.

Aims: The aim of this work is to provide an overview of potential biomarkers that could improve the prognostic value of KCC.

Results: Several promising biomarkers involved in related pathophysiological processes have been identified. Some could be as stand-alone biomarkers; however, the best prognostic values have been observed in the combination of biomarkers with current models. Among these, the ALFSG Index that combines clinical parameters and circulating blood levels of CK18 claims a higher prognostic value than KCC.

Conclusions: In this review, all potential biomarkers for ALF have been summarized to give an overview of the work performed over the last years, and a glimpse of what to expect in this field in the coming years.}},
  author       = {{De Clercq, Pauline and Geerts, Anja and Van Vlierberghe, Hans and Verhelst, Xavier}},
  issn         = {{1386-6346}},
  journal      = {{HEPATOLOGY RESEARCH}},
  keywords     = {{FREE GC-GLOBULIN,ALPHA-FETOPROTEIN,PREDICTIVE-VALUE,SPONTANEOUS-RECOVERY,FULMINANT-HEPATITIS,ARTERIAL AMMONIA,BLOOD,LACTATE,SERUM-LEVELS,CELL-DEATH,TRANSPLANTATION,acute liver failure,biomarker,prognosis}},
  language     = {{eng}},
  pages        = {{8}},
  title        = {{The utility of biomarkers in prognosis assessment of patients with acute liver failure}},
  url          = {{http://dx.doi.org/10.1111/hepr.13668}},
  year         = {{2021}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: